CClinicalTrials.gg
CompletedNCT01938963COACHUpdated Apr 17, 2019

Chinese Older Adults-Collaboration in Health (COACH)Study

An interventional study of Collaborations in Health (COACH) in Depression and Hypertension, sponsored by University of Rochester. Completed at 7 sites in 2 countries. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2019-04-17.

Sponsored by University of Rochester · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
2,685
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

This study will see if education of village doctors and aging workers in identification and management of hypertension and depression, using standardized procedures,consultation with a psychiatrist as needed, and collaborations between the village doctor and aging worker in care elderly patients in the village better achieve better outcomes for their depression and high blood pressure than usual care.

Read the detailed description

The Depression/Hypertension in Chinese Older Adults - Collaborations in Health (COACH) Study is a randomized controlled trial (RCT) comparing the COACH intervention to care as usual (CAU) for the treatment of comorbid depression and hypertension (HTN) in Chinese older adult rural village residents. COACH integrates the care provided by the older person's primary care provider (PCP) with that delivered by an Aging Worker (AW; a lay member of the village's Aging Association), supervised by a psychiatrist consultant. Based on chronic disease management principles, the PCP is trained to use evidence based practice guidelines for treatment of both HTN and depression, and provided with access to mental health consultation regarding optimal management of the patient's depression. The AW is trained to conduct a systematic assessment of the older person's social context to identify and reduce social and environmental barriers to treatment adherence and response. AWs participate with the PCP in developing multidisciplinary care plans for their shared patients, reinforce treatment adherence and adoption of healthy behaviors, and emphasize activation and engagement of the older person in activities designed to improve their connectedness to others and to the community. Finally, PCP, AW, and Psychiatrist Consultant are trained to collaborate in their shared clients' care.

One hundred and sixty villages will be randomized to deliver COACH or CAU to eligible subjects who reside there (approximately 15 per village will meet criteria), or a total of about 2400 subjects. Treatment will continue for one year, with research evaluations at baseline, 3 6, 9, and 12 months.

Specific aims of the study are to determine whether COACH is more effective than CAU in treating depression (Aim 1) and HTN (Aim 2); whether improvements in treatment adherence precede reductions in depression and improvement in BP control (Aim 3a), and whether improvements in depression symptoms precede improvements in BP control (Aim 3b); if COACH is associated with greater improvements in health related quality of life than CAU (Aim 4); and to compare the costs associated with each approach (Aim 5).

02

Conditions studied

  • Depression
  • Hypertension

Keywords

  • Depression
  • Hypertension
  • Older Adults
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 2,685 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Community-dwelling residents registered to the selected village, and thus also registered patients of the village's PCP.
  • Age ≥ 60 years, the typical retirement age in rural China.
  • Clinically significant depression defined as baseline PHQ-9 score ≥ 10.
  • Diagnosis of hypertension
  • Intact cognitive functioning (6-Item Screener score \<3) to assure ability to participate with the treatment team in management of their conditions.
  • Capable of independent communication
  • Capacity to give informed consent.

Exclusion criteria

Exclusion Criteria:

  • Incapable (no capacity) of giving verbal consent to this study.
  • Acute high suicide risk at baseline assessment. Patients assessed to be dangerously suicidal at later assessments will be discontinued from the study, their providers notified, and their safety guaranteed.
  • Psychosis, alcoholism. We exclude patients with psychosis or active alcoholism in the past 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,685 participants (actual)

Study arms

  • No intervention
    Care as usual
  • Experimental
    Collaborations in Health (COACH)

    COACH integrates the care provided by the older person's primary care provider (PCP) with that delivered by an Aging Worker (AW; a lay member of the village's Aging Association), supervised by a psychiatrist consultant. Based on chronic disease management principles, the PCP is trained to use evidence based practice guidelines for treatment of both HTN and depression, and provided with access to mental health consultation regarding optimal management of the patient's depression. The AW is trained to conduct a systematic assessment of the older person's social context to identify and reduce social and environmental barriers to treatment adherence and response. AWs participate with the PCP in developing multi-disciplinary care plans for their shared patients, reinforce treatment adherence and adoption of healthy behaviors, and emphasize activation and engagement of the older person in activities designed to improve their connectedness to others and to the community.

    Behavioral: Collaborations in Health (COACH)

Interventions

  • BehavioralCollaborations in Health (COACH)

    Primary care provider, aging worker, and Psychiatrist Consultant are trained to collaborate in their shared clients' care.

06

What researchers measure

Primary outcomes

  1. Depressive symptom change

    The measure for depressive symptom change will be the Hamilton Depression Rating Scale.

    Time frame: baseline, 3-, 6-, and 12-month follow up

Secondary outcomes

  1. Adherence to antidepressant and antihypertensive medication recommendations

    First, the Morisky Medication Adherence Measure will be used. Secondly, a Medication Possession Ratio will be used-a combination of pill counts and verification of pharmacy refills.

    Time frame: baseline, 3-, 6-, 9-, and 12-month follow up

Other outcomes

  1. Hypertension

    Blood pressure readings will be taken at baseline and at follow-ups.

    Time frame: baseline, 3-, 6-, 9-, and 12-month follow-up

  2. Health related quality of life

    Quality of life will be measured using the World Health Organization Quality of Life- short version, WHOQOL-BREF. Satisfaction will be measured with the Client Satisfaction Questionnaire 8-item.

    Time frame: baseline, 3-, 6-, 9-, and 12-month follow up

  3. Costs associated with the intervention

    Two components will be evaluated: program costs associated with adding resources to care as usual, and medical costs attributed to the care of the subjects in each arm.

    Time frame: baseline, 3-, 6-, 9-, and 12-month follow-up

07

Study locations

7 sites
  • Tulane University
    New Orleans, Louisiana 70112-2709, United States
  • Regents of the University of Michigan
    Ann Arbor, Michigan 48109-1274, United States
  • University of Rochester Medical Center
    Rochester, New York 14642, United States
  • University of Pennsylvania
    Philadelphia, Pennsylvania 19104-6205, United States
  • Zhejiang University
    Hangzhou, Zhejiang 310058, China
  • Zhejiang Provincial Committee on Aging
    Hangzhou, 310007, China
  • Zhejiang Provincial Center for Disease Control and Prevention
    Hangzhou, 310051, China
08

References and documents

Publications

  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14. Erratum In: JAMA. 2003 Jul 9;290(2):197. PubMed 12748199 ↗
  • Chen S, Conwell Y, Xue J, Li L, Zhao T, Tang W, Bogner H, Dong H. Effectiveness of integrated care for older adults with depression and hypertension in rural China: A cluster randomized controlled trial. PLoS Med. 2022 Oct 24;19(10):e1004019. doi: 10.1371/journal.pmed.1004019. eCollection 2022 Oct. PubMed 36279299 ↗
  • Chen S, Conwell Y, Xue J, Li LW, Tang W, Bogner HR, Dong H. Protocol of an ongoing randomized controlled trial of care management for comorbid depression and hypertension: the Chinese Older Adult Collaborations in Health (COACH) study. BMC Geriatr. 2018 May 29;18(1):124. doi: 10.1186/s12877-018-0808-1. PubMed 29843644 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01938963
Lead sponsor
University of Rochester
Collaborators
Zhejiang University, University of Pennsylvania, University of Michigan
Responsible party
Yeates Conwell (Professor, University of Rochester) — Principal investigator
First posted
Sep 10, 2013
Start date
Jan 2014
Primary completion
Feb 9, 2018
Completion
Jan 2, 2019
Last update
Apr 17, 2019

Study contacts

Yeates Conwell, MD
principal investigator · University of Rochester
Shulin Chen, MD, PhD
principal investigator · Zhejiang University, Department of Psychology

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion